Ligand Pharmaceuticals Incorporated Earning Date (LGND)

USA |NASDAQ |USD

LGND Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 1, 2022 Dec 2021 $1.85 - $0.35
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 1, 2022 Dec 2021 $75.47M - $69.99M

Ligand Pharmaceuticals Incorporated's next earnings date is Tuesday, Feb 1, 2022 for the fiscal quarter ending Dec 2021.

LGND Earnings Date & History Chart

LGND Earnings & Revenue Forecast

LGND Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $1.85 $1.56 $1.95
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $5.93 $5.83 $6.00
Dec 2022 6 $4.02 $3.30 $5.03

LGND Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $1.85 $1.84 $1.90
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $5.93 $5.93 $6.11
Dec 2022 0 / 0 $4.02 $4.41 $4.95

LGND Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 7 $75.47M $55.23M $86.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $270.82M $264.60M $277.00M
Dec 2022 7 $191.57M $159.10M $231.00M

LGND Earnings Date & Revenue History

LGND Earnings History

|
Show More
Show More

LGND Revenue History

|
Show More
Show More

Ligand Pharmaceuticals Incorporated Next Earnings Date & Report

LGND Next Earnings Date & Report Preview: Dec 2021 (FQ)

LGND's next earnings date is Tuesday, Feb 1, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Ligand Pharmaceuticals Incorporated's next quarterly earnings is $1.85, with a low EPS estimation of $1.56, and a high estimation of $1.95.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $1.85, the last 2 month trend is $1.84, and the 3 month trend is $1.90.

Based on analysts, the average revenue estimation is $75.47M, with a low revenue estimation of $55.23M, and a high estimation of $86.00M.

Ligand Pharmaceuticals Incorporated Previous Earnings Dates & Reports

LGND Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Ligand Pharmaceuticals Incorporated's previous earnings date was Nov 9, 2021 for its fiscal quarter ended Sep 30, 2021.

LGND Previous Earnings Date & Report Recap: Dec 2020 (FY)

Ligand Pharmaceuticals Incorporated's previous annual earnings date was Feb 3, 2021 for its fiscal year ended Dec 31, 2020.

LGND's earnings per share (EPS) was $-0.21, missing the consensus analysts forecast of $3.92 by -105.36% , and lower than the previous year's EPS (Dec 2019) by -100.72%.

Revenues were $186.42M, better than the forecast of $170.46M by 9.36%, and up by 54.98% from previous year's revenue.

The company reported a net income of $-2.98M.

Ligand Pharmaceuticals Incorporated reported a free cash flow of $50.13M for its fiscal year, compared to $-31.89M a year ago.

The company ended the fiscal year with $450.77M in total debt, a decrease of -29.59% compared to the previous year.